Immunoassay for thrombin detection
AssigneeOmrix Biopharmaceuticals Ltd.
InventorsRoni Mintz, Nadav Orr, Israel Nur
Life of this patent
Estimating the term…
Abstract
The invention relates to an in vitro immunoassay for quantifying thrombin in a sample comprising anti-thrombin III (AT-III) and thrombin. The method comprises the following steps: contacting the sample with a small molecule that recognizes the substrate binding site of thrombin; contacting the thrombin with a thrombin specific antibody raised against a thrombin blocked in the active site; and measuring the level of bound antibody.
Claims3
A kit for quantifying thrombin in a sample comprising anti-thrombin III (AT-III), the kit comprises a thrombin specific antibody or a fragment thereof and a small molecule that recognizes the substrate binding site of thrombin and is selected from the group consisting of naturally occurring hirudin, synthetic hirudin variants, hirudin derivatives, recombinant hirudin variants, mimics, and a combination thereof, wherein the thrombin specific antibody consists of a polyclonal antibody and is raised against a thrombin having a blocked active site with a molecule selected from the group consisting of Phe-Pro-Arg-chloromethylketone (PPACK), 4-aminophenylpyruvic acid (APPA), 4-(2-aminoethyl) benzenesulfonyl fluoride (AEBSF), and combinations thereof.
Dependencies are inferred from the claim text.